fda semaglutide shortage list Declares of Novo Nordisk's Wegovy, Ozempic Over FDA ends semaglutide shortage, closing

Traveling with reconstituted peptides is challenging but possible

IM suits volumes above 1 mL and absorbs faster

At Open Road Psych, we listen, validate, and empower

Pre-clinical trials have shown favorable toxicity results, and it is considered to be safe by most researchers

Purification of naturally occurring peptides by reversed-phase HPLC

Source: AAN For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency department visits and hospitalizations overall, and with less need for medications used to stop and prevent migraine attacks, according to a preliminary study released March 1, 2026, that will be presented at the American Academy of Neurologys 78 th Annual Meeting taking place April 18-22, 2026, in Chicago and online